BRENTUXIMAB VEDOTIN IN COMBINATION WITH LENALIDOMIDE AND RITUXIMAB IN SUBJECTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) (TRIAL IN PROGRESS)

Saved in:
Bibliographic Details
Published in:Hematological oncology 2021-06, Vol.39 (S2)
Main Authors: Bartlett, N. L., Yasenchak, C. A., Ashraf, K. K., Harwin, W. N., Sims, R. B., Nowakowski, G. S.
Format: Article
Language:English
Subjects:
B-cell lymphoma
Immunotherapy
Lymphoma
Monoclonal antibodies
Rituximab
Targeted cancer therapy
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0278-0232
1099-1069
DOI:10.1002/hon.166_2880